HomeB.ScMaithri Laboratories walk-in for Freshers on 31st May 2024

Maithri Laboratories walk-in for Freshers on 31st May 2024

Maithri Drugs, an emerging pharmaceutical company in India, has gained significant recognition for its focus on active pharma ingredients (APIs). Renowned for its exceptional research and development efforts and ambitious growth strategies, Maithri has established its credibility with 50 US DMFs and 22 CEPs within a short period of time. Situated in Hyderabad, our manufacturing facility has undergone rigorous audits and received approval from the US FDA.

We extend our warm greetings from Maithri Laboratories (MSN Group). We are pleased to announce that we will be organizing walk-in interviews for Freshers in Production, QC, R&D, and Engineering at Maithri Laboratories Pvt. Ltd (MLPL) Unit II Choutuppal on the 31st of May 2024, which falls on a Friday.

Department: Production / Quality Control / R&D/ Engineering
Required Experience: Freshers
Qualification: B.Sc. Chemistry/ M.Sc. Chemistry/ ITI Fitter
Eligibility: 2021/22/23/24 Passed outs only
Designation: Trainee

Walk-In Interview Details: 
Date of interview: 31st May 2024 (Friday)
Time: 9.30 a.m to 12.00 p.m
Venue: Maithri Laboratories Pvt. Ltd, Unit-II, Choutuppal(M), Yadadri Bhuvangiri (D), Telangana.

BENEFITS:

  1. Night shift allowance.
  2. Free Transportation.
  3. Subsidized Canteen.

Please Note: Those who are not able to attend the interview can send their resumes to nagaganesh.patnaik@msnlabs.com

Candidates Are Requested to Bring:
Resume,
Photo Copy of Educational Certificates,
Aadhar Card Copy

Maithri Laboratories walk-in for Freshers on 31st May 2024

0/5 (0 Reviews)

Discover more from Pharma Walks

Subscribe to get the latest posts sent to your email.

RELATED JOBS

Join us

3,654FansLike
5,353FollowersFollow
4,233FollowersFollow
9,843SubscribersSubscribe

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Discover more from Pharma Walks

Subscribe now to keep reading and get access to the full archive.

Continue reading